DDC
WST icon

DF Dent & Co’s West Pharmaceutical WST Stock Holding History

DF Dent & Co’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Sell
4,552
-116,045
-96% -$35.5M 0.03% 146
2026
Q1 		$30.2M Sell
120,597
-198,985
-62% -$49.5M 0.58% 52
2025
Q4 		$87.9M Sell
319,582
-64,123
-17% -$17.5M 1.27% 28
2025
Q3 		$101M Sell
383,705
-11,569
-3% -$2.81M 1.3% 28
2025
Q2 		$86.5M Sell
395,274
-44,024
-10% -$9.41M 1.1% 31
2025
Q1 		$98.3M Buy
439,298
+42,202
+11% +$11.6M 1.31% 30
2024
Q4 		$130M Sell
397,096
-56
-0% -$17.6K 1.65% 25
2024
Q3 		$119M Buy
397,152
+98,564
+33% +$30.2M 1.45% 26
2024
Q2 		$98.4M Buy
298,588
+38,654
+15% +$13.7M 1.27% 29
2024
Q1 		$103M Buy
259,934
+182,443
+235% +$67.5M 1.26% 30
2023
Q4 		$27.3M Sell
77,491
-1,789
-2% -$633K 0.36% 55
2023
Q3 		$29.7M Sell
79,280
-466
-0.6% -$180K 0.44% 52
2023
Q2 		$30.5M Buy
79,746
+2,902
+4% +$1.04M 0.41% 54
2023
Q1 		$26.6M Sell
76,844
-307
-0.4% -$89.7K 0.38% 52
2022
Q4 		$18.2M Buy
+77,151
New +$18.3M 0.27% 58

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

DF Dent & Co's WST Position: Q2 2026 in Review

DF Dent & Co reduced its West Pharmaceutical (WST) stake by 96% in Q2 2026, selling an estimated $35.5M and leaving 4,552 shares worth $1.63M. The position accounts for 0.03% of the portfolio, ranked #146.

DF Dent & Co first reported a position in WST in Q4 2022 and has held it in 15 quarters since. The position peaked at $130M in Q4 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • DF Dent & Co held 4,552 shares of West Pharmaceutical worth $1.63M as of Q2 2026.
  • DF Dent & Co sold 116,045 West Pharmaceutical shares in Q2 2026, an estimated $35.5M.
  • West Pharmaceutical made up 0.03% of DF Dent & Co's portfolio in Q2 2026, its #146 holding.
  • DF Dent & Co first reported a position in West Pharmaceutical in Q4 2022 and has held it in 15 quarters since.
  • DF Dent & Co's West Pharmaceutical position peaked at $130M in Q4 2024.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on DF Dent & Co's 13F filing for Q2 2026, filed 14 Aug 2026.